about
Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS(E) data collection technique.Simultaneous determination of eight major steroids from Polyporus umbellatus by high-performance liquid chromatography coupled with mass spectrometry detections.Rapid resolution liquid chromatography-mass spectrometry and high-performance liquid chromatography-fluorescence detection for metabolism and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one.Pharmacokinetics of ergosterol in rats using rapid resolution liquid chromatography-atmospheric pressure chemical ionization multi-stage tandem mass spectrometry and rapid resolution liquid chromatography/tandem mass spectrometry.Ultra performance liquid chromatography coupled with electrospray and atmospheric pressure chemical ionization (ESCi)-quadrupole time-of-flight mass spectrometry with novel mass spectrometry(Elevated Energy) (MS(E)) data collection technique: determQuantitative HPLC method and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one, a natural product with diuretic activity from Polyporus umbellatus.Quality control of natural product medicine and nutrient supplements 2014Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm.Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanismTraditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) Fries: a review.UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry.A pharmaco-metabonomic study on chronic kidney disease and therapeutic effect of ergone by UPLC-QTOF/HDMSUrinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS.Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease.Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathyTraditional uses, fermentation, phytochemistry and pharmacology of Phellinus linteus: A review.Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosisUrinary biomarker and treatment mechanism of Rhizoma Alismatis on hyperlipidemia.An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure.Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.Using the Doubly Charged Selected Ion Coupled with MS/MS Fragments Monitoring (DCSI-MS/MS) Mode for the Identification of Gelatin Species.Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications.Metabolomics in nephrotoxicity.Metabolomics in dyslipidemia.Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.Traditional uses, phytochemistry, pharmacology, toxicology and quality control of Alisma orientale (Sam.) Juzep: a review.Lipidomics applications for disease biomarker discovery in mammal models.Lipidomics: new insight into kidney disease.Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.Power and sample size calculations for high-throughput sequencing-based experiments.Metabolomic application in toxicity evaluation and toxicological biomarker identification of natural product.Research Progress of Natural Product Gentiopicroside - a Secoiridoid Compound.Synthesis and biological evaluation of a folate-targeted rhaponticin conjugate.Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine.Cytotoxicity of Fe3O4/Au composite nanoparticles loaded with doxorubicin combined with magnetic field.Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia.Bioactivity-directed isolation, identification of diuretic compounds from Polyporus umbellatus.Aggregation-induced emission of 1,8-naphthalimide-casein micelle: investigation by synchronous spectrographic method.Intrarenal metabolomic investigation of chronic kidney disease and its TGF-β1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MS(E).
P50
Q30571181-407047E5-1408-4CE7-ADBA-4B6F78D20AFAQ33442967-920B8ACC-586F-4F77-97C4-111A89ED081EQ33447733-70F2B27A-3D14-4EFD-B759-F6066CA61ED8Q33450807-732811F4-5D71-4432-ABE8-F5DB3100D305Q33455043-C5AE6DDA-094B-4A74-9DE2-111EC931929CQ33696219-06BE8D4A-83CB-4CBF-8D85-7BDEEED89FB6Q34273492-06B92764-B972-45C6-8BFE-C6C313B6B132Q34300276-EFB8BF9E-2CE0-449B-8164-B382A924EA73Q34651679-8DDE5136-2BF9-45F5-85B5-48C6FEF82F7AQ34786765-84F1CB27-E4B0-4BB7-A603-B8BBC19A9E08Q35217999-5F2B901F-616E-4AB5-B026-C12724BAC479Q35533024-EE056669-46AD-4122-85CA-F2886303825EQ35600812-357CACC9-669E-4EE9-BEB6-2E08EE22B3E8Q35769873-80DE9DB9-C1B8-4843-A505-13BE0A4F354AQ35926121-7AE99678-8B31-4471-A025-BBC9A003128DQ36061590-3A325509-6300-427A-BCA5-3AD155DBFD9CQ36100197-A8B01F52-39BE-4C8F-9CD2-69CD65E62F21Q36116155-F489F456-A352-4C98-AD2C-337220A8AEC1Q36606173-2F0F23C3-213C-47B7-B307-14B9FAEDB7E0Q37343636-8E2FF0D8-FDC4-420B-AEF1-74BCAB7E967FQ37686789-F417A755-50BD-493D-827E-BDE8518EFD64Q37724958-21EB2D61-D0C3-42E1-8816-F7960F07D1A0Q38228422-0E03DDB1-980D-4BCA-B3EF-F67E21B1F8CFQ38252338-7B7A8037-A899-49CC-9274-DA98BA1A43A3Q38262695-3BC9ED6C-EA9D-4A0B-A956-CD53EAE38EF6Q38265745-A93EA0E6-3844-4D97-9095-09712EA2F922Q38275021-3578892A-EB60-488C-90B3-F16EC90CB897Q38358769-B0496C4C-F5C8-4F4F-B83B-169CC00DB0BDQ38413786-3B3A70C9-11BC-48E0-96E8-DF3734520ACDQ38425357-47D15442-28A7-4C15-9400-12A88624BCFBQ38729920-6139BA70-B5C6-48A7-88E9-B7F7394762C8Q38797231-3D720A3B-C6D9-4B89-85C1-FC91C0D0BD7BQ38876248-B94706D2-C233-4C4F-9BD5-37FE0EC83861Q39239879-5B02B052-E224-4BE4-AAF8-2B5B373DDCE7Q39376390-F0337C07-2090-413A-9CB5-08EF052D541DQ39675287-F6D72ECF-AF2B-4D3F-B430-72BBC4A2674BQ41529652-9B41FD5E-BC94-4EE4-9D8C-7125E7A106F8Q43295758-E4AD8060-DCA5-427F-B232-FA9AA9735F26Q43499617-E8DD1552-A466-4297-87D0-AD280BBB7533Q44534069-8A22827A-B1F1-4741-B631-FB268EEECDFE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ying-Yong Zhao
@ast
Ying-Yong Zhao
@en
Ying-Yong Zhao
@es
Ying-Yong Zhao
@nl
type
label
Ying-Yong Zhao
@ast
Ying-Yong Zhao
@en
Ying-Yong Zhao
@es
Ying-Yong Zhao
@nl
prefLabel
Ying-Yong Zhao
@ast
Ying-Yong Zhao
@en
Ying-Yong Zhao
@es
Ying-Yong Zhao
@nl
P1153
P106
P1153
56626232200
57195958843
7406635027
P31
P496
0000-0002-0239-7342